ArticleHCA healthcare journal of medicine2022
Comprehensive Care to Improve Quality of Life: A Case of Childhood Adrenoleukodystrophy.
Article in HCA healthcare journal of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Description The childhood cerebral form of adrenoleukodystrophy (ALD) causes rapid demyelination of cerebral white matter and is clinically characterized by hyperactivity, emotional changes, and poor school performance, as well as progressive cognitive, visual, auditory, speech, and motor decline. While aggressive behavior is a known complication of ALD, treatment of the disease is limited. Moreover, behavioral management is not well described in the available literature, particularly from a psychiatric standpoint. In this case presentation, the patient's parents reported significant agitation and aggression, which may have been secondary to verbal deficits, in addition to the general neuropathological implications of this disease. Although this patient's previously prescribed pharmacotherapy was controlling most of his symptoms, the parents were understandably resistant to a treatment strategy that was so sedating. Therefore, modifications in the patient's original medical therapy were made, including a 50% decrease in his risperidone dosage. He was also referred to a behavioral therapist specializing in autism and speech therapy. He received Applied Behavior Analysis therapy, which was modified to teach a simplified method of communication using shapes identified by tactile sensation. At his 7-month follow-up, the parents reported noticeable improvement in the child's behavior and communication as well as fewer episodes of aggression. Quality of life is of the utmost importance for patients with such a limited life span. Medical care must be individualized for patients with ALD in ways that will enhance their quality of life, focusing on counseling, behavioral management, and interventions designed to address communication difficulties and strengthen social relationships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.